Medication analysis
Conditions
Interventions
Group 1: This study is a descriptive, exploratory, single-center study.
The study is divided into two parts.
1. A purely retrospective analysis of medication plans and, if applicable, related feedbac
Sponsors
Lehrstuhl für klinische Pharmakologie der Friedrich-Alexander-Universität Erlangen-Nürnberg
Eligibility
Sex/Gender
All
Age
66 Years to No maximum
Inclusion criteria
Inclusion criteria: Taking at least five different medications
Exclusion criteria
Exclusion criteria: Missing declaration of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main questions - How do drug-drug interactions change in a geriatric patient collective living in senior and care facilities, which are often characterized by multimorbidity and polypharmacy, after notification to the responsible doctor by the pharmacy in terms of occurrence and frequency? - How is it - with the same group of patients - in comparison with drug diagnosis contraindications? The target parameters of this study are the drug-drug interactions, the drug diagnosis contraindications and the resulting individual drug therapy safety for the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ancillary questions - Are intervention suggestions implemented by the pharmacy by doctors? If yes, which? Which not and why? | — |
Countries
Germany
Contacts
Public ContactChristian Führling
Lehrstuhl für klinische Pharmakologie der Friedrich-Alexander-Universität Erlangen-Nürnberg
Outcome results
None listed